Drug development prize bill hearings

Public hearings May 15, 2012 at Senate HELP committee. “De-linkage” proposals are an alternative to intellectual property that separate the market for R&D from the market for pills.  De-linkage has surprising support from academics, health access advocates and drug companies.

Prior TIE coverage here.  Much more extensive materials from Jamie Love/KEI here.
@koutterson

Share on twitter
Share on facebook
Share on linkedin
Share on reddit
Share on email

Hidden information below

Subscribe

* indicates required
Email Format